DXCM (STOCKS)
DexCom, Inc.
$91.440000
+0.640000 (+0.70%)
Prev close: $90.800000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Jacob S. Leach
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $35,912.63M
- Employees
- 10,300
- P/E (TTM)
- 35.84
- P/B (TTM)
- 13.07
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $4.97B |
| Benefits Costs and Expenses | $3.69B |
| Cost Of Revenue | $1.86B |
| Costs And Expenses | $3.69B |
| Gross Profit | $3.10B |
| Operating Expenses | $1.97B |
| Selling, General, and Administrative Expenses | $1.36B |
| Depreciation and Amortization | $45.20M |
| Research and Development | $604.00M |
| Operating Income/Loss | $1.14B |
| Income/Loss From Continuing Operations After Tax | $999.70M |
| Income/Loss From Continuing Operations Before Tax | $1.28B |
| Income Tax Expense/Benefit | $280.30M |
| Income Tax Expense/Benefit, Deferred | $196.90M |
| Net Income/Loss | $999.70M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $999.70M |
| Net Income/Loss Available To Common Stockholders, Basic | $999.70M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $2.59 |
| Diluted Earnings Per Share | $2.52 |
| Basic Average Shares | 773,600,000 |
| Diluted Average Shares | 797,000,000 |
| Assets | $6.46B |
| Current Assets | $4.09B |
| Inventory | $726.40M |
| Prepaid Expenses | $70.70M |
| Other Current Assets | $3.29B |
| Noncurrent Assets | $2.37B |
| Intangible Assets | $101.60M |
| Other Non-current Assets | $2.27B |
| Liabilities | $3.83B |
| Current Liabilities | $2.36B |
| Wages | $136.30M |
| Other Current Liabilities | $2.22B |
| Noncurrent Liabilities | $1.48B |
| Equity | $2.62B |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $2.62B |
| Liabilities And Equity | $6.46B |
| Net Cash Flow From Operating Activities | $1.75B |
| Net Cash Flow From Operating Activities, Continuing | $1.75B |
| Net Cash Flow From Investing Activities | $530.70M |
| Net Cash Flow From Investing Activities, Continuing | $530.70M |
| Net Cash Flow From Financing Activities | -$2.33B |
| Net Cash Flow From Financing Activities, Continuing | -$2.33B |
| Exchange Gains/Losses | -$5.00M |
| Net Cash Flow | -$55.10M |
| Net Cash Flow, Continuing | -$50.10M |
| Comprehensive Income/Loss | $1.01B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $1.01B |
| Other Comprehensive Income/Loss | $1.01B |
| Other Comprehensive Income/Loss Attributable To Parent | $6.40M |